:: Library Catalog

Cover Image

Saved in:

Bibliographic Details
Main Author:	Mamoor, Shahan
Format:	Recurso digital
Language:
Published:	Zenodo 2025
Online Access:	https://doi.org/10.5281/zenodo.17938583
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

ATM defects result in Xist modulation.
by: Mamoor, Shahan
Published: (2025)

Xist is activated during resistance in triple negative breast cancer in vitro.
by: Mamoor, Shahan
Published: (2025)

Deletion of repeat B and C of Xist results in induction of SATB1.
by: Mamoor, Shahan
Published: (2026)

The range of Xist transcriptional targets in non-small cell lung cancer: MYC.
by: Mamoor, Shahan
Published: (2025)

The range of Xist transcriptional targets in non-small cell lung cancer: BTBD7.
by: Mamoor, Shahan
Published: (2025)

The genes encoded at the Dxz locus, DANT2/3, are components of an Xist gene expression regulation apparatus that utilizes quantitative control of message quantity of specific genes to measure and maintain transcription, globally, within homeostatic range.
by: Mamoor, Shahan
Published: (2025)

Developmental stage-specific control of proliferation and senescence by EZH2.
by: Mamoor, Shahan
Published: (2025)

SLX1B is active during transformation and controls relapse and resistance in human cancer.
by: Mamoor, Shahan
Published: (2025)

Disparate immune receptor control by p53 sufficient and p53 deficient cancers.
by: Mamoor, Shahan
Published: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CNTNAP2.
by: Mamoor, Shahan
Published: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CMC2.
by: Mamoor, Shahan
Published: (2026)

SSX2IP induction in basal subtype breast cancer.
by: Mamoor, Shahan
Published: (2025)

Therapeutic targeting in colorectal cancer for the treatment of the primary tumor: SKP2.
by: Mamoor, Shahan
Published: (2025)

ECT2 is a sensitive and specific marker of transformation in the human breast.
by: Mamoor, Shahan
Published: (2025)

ECT2 is a sensitive and specific marker of transformation in the human breast.
by: Mamoor, Shahan
Published: (2025)

Therapeutic targeting in breast cancer for the treatment of lung metastasis: SHMT2.
by: Mamoor, Shahan
Published: (2025)

An expression screen to identify genes important for trastuzumab resistance: Meox2.
by: Mamoor, Shahan
Published: (2026)

Clec2b and Clec11a, co-receptors for KIR2DL3 natural killer cell self discrimination complexes, are altered in expression in the cells of patients with IBD.
by: Mamoor, Shahan
Published: (2025)

ABCG2 functions in multi-drug resistance in human cancer in metastasis to the bone.
by: Mamoor, Shahan
Published: (2025)

BCL2L1 induction in metastasis to the brain in humans with breast cancer.
by: Mamoor, Shahan
Published: (2025)

Therapeutic targeting in breast cancer for the treatment of lymph node metastasis: DNAI2.
by: Mamoor, Shahan
Published: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: AIM1.
by: Mamoor, Shahan
Published: (2025)

Immunoglobulin-based therapeutic targeting in breast cancer for the treatment of liver metastasis: ACSM2B.
by: Mamoor, Shahan
Published: (2025)

Therapeutic targeting in breast cancer for the treatment of metastasis to the skeletal system: MAP2K3.
by: Mamoor, Shahan
Published: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: MSL1.
by: Mamoor, Shahan
Published: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: ADGRF1.
by: Mamoor, Shahan
Published: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CD80.
by: Mamoor, Shahan
Published: (2025)

Phosphatase targeting in HER2+ breast cancer to prevent and treat CNS disease: PTPN13.
by: Mamoor, Shahan
Published: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CDK4.
by: Mamoor, Shahan
Published: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CPAMD8.
by: Mamoor, Shahan
Published: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CDC45.
by: Mamoor, Shahan
Published: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: ENPP3.
by: Mamoor, Shahan
Published: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: DNAAF5.
by: Mamoor, Shahan
Published: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: EFNA4.
by: Mamoor, Shahan
Published: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: CHORDC1.
by: Mamoor, Shahan
Published: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: DEPDC1.
by: Mamoor, Shahan
Published: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: ERO1A.
by: Mamoor, Shahan
Published: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: FAM129B.
by: Mamoor, Shahan
Published: (2026)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: SLC1A1.
by: Mamoor, Shahan
Published: (2025)

Therapeutic targeting in HER2+ breast cancer to prevent and treat CNS disease: EIF4G1.
by: Mamoor, Shahan
Published: (2026)